Urinary Bladder
Urethral Obstruction
Administration, Intravesical
Carcinoma, Transitional Cell
Indigo Carmine
Diagnostic Techniques, Urological
Urology
Urinary Bladder Calculi
Urologic Surgical Procedures
Urinary Bladder Fistula
Aminolevulinic Acid
Cystitis, Interstitial
Ureteral Neoplasms
Ureter
Hematuria: an unusual presentation for mucocele of the appendix. Case report and review of the literature. (1/259)
Mucocele of the appendix is a nonspecific term that is used to describe an appendix abnormally distended with mucus. This may be the result of either neoplastic or non-neopleastic causes and may present like most appendiceal pathology with either mild abdominal pain or life-threatening peritonitis. Urologic manifestations of mucocele of the appendix have rarely been reported. Laparoscopy can be used as a diagnostic tool in equivocal cases. Conversion to laparotomy may be indicated if there is a special concern for the ability to remove the appendix intact or if more extensive resection is warranted, as in malignancy. We here report our experience with a woman presenting with hematuria whose ultimate diagnosis was mucocele of the appendix, and we review the appropriate literature. This case highlights the mucocele as a consideration in the differential diagnosis of appendiceal pathology and serves to remind the surgeon of the importance for careful intact removal of the diseased appendix. (+info)The value of intra-operative cystoscopy at the time of laparoscopic hysterectomy. (2/259)
The aim of this study was to determine the usefulness of routine intra-operative cystoscopy in documenting ureteral injury during total laparoscopic hysterectomy with vault suspension and to document the incidence of this complication in a large series. The charts of 118 patients who underwent laparoscopic hysterectomy with vault suspension from January 1992 to January 1998 were retrospectively reviewed. The patients underwent intra-operative cystoscopic evaluation to verify ureteral permeability and bladder integrity. Intra-operative ureteral obstruction occurred in four patients (3.4%). All complications were immediately fixed and there were no postoperative ureteral problems. No late ureteral complications were observed. Intra-operative cystoscopy allows for early recognition and treatment of obstructive ureteral injuries and may reduce the rate of late postoperative complications during advanced laparoscopic procedures. (+info)Intrathecal bupivacaine in humans: influence of volume and baricity of solutions. (3/259)
BACKGROUND: The effects of volume and baricity of spinal bupivacaine on block onset, height, duration, and hemodynamics were studied. METHODS: Ninety patients undergoing endoscopic urologic procedures were randomized to receive 10 mg of intrathecal bupivacaine at L2-L3 level in sitting position. In the operating room, commercial products were diluted as needed with NaCl 0.9% to obtain isobaric solutions (density, 1.005-1.008) or with NaC 10.9% and glucose 30% to obtain hyperbaric solutions (density, 1.031-1.037) of 2, 5, or 10 ml (six groups of 15 patients each). Three minutes after spinal injection the patients were placed in lithotomy position. Sensory blockade was assessed using pinprick and cold sensation tests, and motor blockade was assessed using a four-point scale. RESULTS: Onset times to maximal cephalad spread of spinal blockade were similar with isobaric and hyperbaric solutions. A greater maximal cephalad spread of anesthesia was obtained with diluted isobaric bupivacaine but was not associated with more hypotension. Volume had no effect on cephalad extent of anesthesia with hyperbaric bupivacaine. Times for regression of anesthesia to L2 and offset of motor block were longer with isobaric than with hyperbaric solutions of bupivacaine. The intensity of motor blockade was decreased with diluted hyperbaric bupivacaine. No patient reported back pain. CONCLUSION: In this study, volume had no significant influence on either cephalad spread or duration of sensory blockade for either isobaric or hyperbaric bupivacaine. Time for offset of anesthesia was shorter with hyperbaric bupivacaine compared with isobaric solutions. (+info)Early fetal megacystis between 11 and 15 weeks of gestation. (4/259)
OBJECTIVE: The purpose of this study was to evaluate the prognostic criteria of early fetal megacystis. DESIGN: A prospective, transvaginal ultrasound, cross-sectional study at 11-15 weeks of gestation at a tertiary referral fetal medicine unit. SUBJECTS AND METHODS: Sixteen pregnancies out of a total of 5240 were identified with early fetal megacystis. Fetal biometry, morphology, amniotic fluid, bladder size and volume were also evaluated. The karyotype was available in 15 cases. Vesicocentesis was performed in six fetuses and three had concomitant cystoscopies. RESULTS: In six fetuses, the megacystis was isolated. In the remaining ten, we detected associated hygroma (n = 5), nuchal translucency (n = 3), omphalocele (n = 1), mild pyelectasis (n = 1) and bilateral talipes (n = 1). In three cases the fetuses demonstrated renal hyperechogenicity with cysts, and in two cases oligohydramnios was found; four cases (25%) had chromosomal abnormalities; 47, XY + 13 (two cases), 47, XY + 18 and 47, XY + 21. Only one fetus from this study survived. In the remaining 13 cases, termination was proposed after counselling of the patients on the poor prognosis. The mean gestational age at termination was 15.5 +/- 2.4 weeks (range 12-20). Three fetal transabdominal cystoscopies did not allow us to view the valves; one urethral atresia was suspected, and confirmed postnatally. CONCLUSIONS: We found a high rate of associated malformations, especially intestinal malformations. The systematic evaluation of the intestinal enzymes in the amniotic fluid and urine samples might be an important aid in the diagnosis of multiple malformations, such as cloacal dysgenesis. (+info)Interstitial cystitis: a retrospective analysis of treatment with pentosan polysulfate and follow-up patient survey. (5/259)
To evaluate the efficacy and safety of pentosan polysulfate sodium (PPS) in relieving symptoms of interstitial cystitis, the authors retrospectively reviewed charts of 260 patients in whom interstitial cystitis had been diagnosed. Subsequently, they conducted a follow-up phone interview or mail survey of those patients who were treated with PPS to investigate changes in the patients' symptoms, adverse effects, and change in quality of life. The control group consisted of patients whose interstitial cystitis had been diagnosed at cystoscopy and had a duration of at least 1 year and who had taken at least one or more oral medications for their symptoms. The average length of treatment was 9.3 months among the 27 subjects on PPS therapy. The mean length of time that they had diagnosed interstitial cystitis was 35.63 months and 48.78 months for the PPS-treated and control groups, respectively, with no statistically significant difference. Changes in frequency, urgency, and pain were greater in the treatment group and statistically significant (P = .11, P = .49, and P = .004, respectively). No change occurred in the rate of nocturia in the PPS-treated group compared with that in the control group. Symptoms of both groups improved over time, but improvement was statistically significantly greater in the treatment group (P = .001) over the treatment interval. The most common side effect attributable to PPS was diarrhea in 15% of subjects. Pentosan proved to be an efficacious option for reducing the debilitating symptoms of interstitial cystitis. (+info)Endoscopic treatment of vesicoureteral reflux in children with glutaraldehyde cross-linked bovine dermal collagen. Short-term results. (6/259)
BACKGROUND: Endoscopic treatment using glutaraldehyde cross-linked (GAX) collagen was conducted on 4 children with bilateral primary vesicoureteral reflux (VUR)..... a 1-year-old boy and three 5- to 8-year-old girls $B!D (Ball having a history of repeated hospitalization for fever due to acute pyelonephritis, visiting as pediatric outpatients regularly and receiving antibiotics continuously. By international VUR classification, 4 ureters were grade 3, 2 grade 4, and 2 grade 5. METHODS: After nonallergy to GAX collagen was confirmed intracutaneously, a needle was used through a 9.5 Fr cystoscope channel to puncture bladder mucosa 4 to 5 mm from the affected ureteral orifice at 6 o'clock under general anesthesia; 1.1 to 1.9 ml of GAX collagen was injected immediately below affected orifices. RESULTS: Three months after surgery, voiding cystourethrography showed reflux had disappeared in 6 ureters, for a short-term success rate of 75%. VUR in the Remaining 2 ureters improved from grade 3 to 1 and from grade 5 to 4. No postoperative urinary tract infection occurred and antibiotics were stopped. CONCLUSION: Since GAX collagen is less viscous than Teflon paste, it is easily injected into submucosa, does not form granuloma or migrate to other organs, and is noncarcinogenic. Endoscopic VUR treatment using GAX collagen is indicated when less invasion and shorter hospitalization are considered, although it requires general anesthesia, which itself involves some risk. (+info)Diseases causing end-stage renal failure in New South Wales. (7/259)
The nature of the original renal disease was determined in 403 consecutive cases of end-stage renal failure, in 317 of which the clinical diagnosis was corroborated by histological examination of the kidney. Five diseases accounted for 20 or more cases--glomerulonephritis (31% of the total), analgesic nephropathy (29%), primary vesicoureteral reflux (8%), essential hypertension (6%), and polycystic kidneys (5%). In only four cases did renal failure result from chronic pyelonephritis without a demonstrable primary cause. Greater use of micturating cystography and cystoscopy and routine urine testing for salicylate are advocated for earlier diagnosis of the major causes of "pyelonephritis". The incidence of end-stage renal failure in people aged 15-55 in New South Wales was estimated to be at least 34 new cases per million of total population each year. (+info)Malignant lymphoma of the urinary bladder: a clinicopathological study of 11 cases. (8/259)
AIM: To report the clinical and histological features and outcome of primary and secondary malignant lymphomas of the urinary bladder. METHODS: Eleven cases of malignant lymphoma of the urinary bladder were obtained from the registry of cases at St Bartholomews and the Royal London Hospitals. The lymphomas were classified on the basis of their morphology and immunophenotype, and the clinical records were reviewed. RESULTS: There were six primary lymphomas: three extranodal marginal zone lymphomas of mucosa associated lymphoid tissue (MALT) type and three diffuse large B cell lymphomas. Of the five secondary cases, four were diffuse large B cell lymphomas, one secondary to a systemic follicular follicle centre lymphoma, and one nodular sclerosis Hodgkins disease. Four patients with secondary lymphoma for whom follow up was available had died of disease within 13 months of diagnosis. Primary lymphomas followed a more indolent course. In one case, there was evidence of transformation from low grade MALT-type to diffuse large B cell lymphoma. The most common presenting symptom was haematuria. Cystoscopic appearances were of solid, sometimes necrotic tumours resembling transitional cell carcinoma, and in one case the tumours were multiple. These cases represented 0.2% of all bladder neoplasms. CONCLUSIONS: Diffuse large B cell lymphoma and MALT-type lymphoma are the most common primary malignant lymphomas of the bladder. Lymphoepithelial lesions in MALT-type lymphoma involve transitional epithelium, and their presence in high grade lymphoma suggests a primary origin owing to transformation of low grade MALT-type lymphoma. Primary and secondary diffuse large B cell lymphomas of the bladder are histologically similar, but the prognosis of the former is favourable. (+info)These tumors can be benign or malignant, and their growth and behavior vary depending on the type of cancer. Malignant tumors can invade the surrounding tissues and spread to other parts of the body through the bloodstream or lymphatic system, causing serious complications and potentially life-threatening consequences.
The risk factors for developing urinary bladder neoplasms include smoking, exposure to certain chemicals, recurrent bladder infections, and a family history of bladder cancer. The symptoms of these tumors can include blood in the urine, pain during urination, frequent urination, and abdominal pain.
Diagnosis of urinary bladder neoplasms is typically made through a combination of imaging tests such as ultrasound, computed tomography (CT) scan or magnetic resonance imaging (MRI), and cystoscopy, which involves inserting a flexible tube with a camera into the bladder to visualize the tumor.
Treatment options for urinary bladder neoplasms depend on the type of cancer, stage, and location of the tumor. Treatment may include surgery to remove the tumor, chemotherapy, radiation therapy, or a combination of these modalities. Early detection and treatment can improve the prognosis for patients with urinary bladder neoplasms.
Urinary bladder diseases refer to any conditions that affect the urinary bladder, which is a hollow organ in the pelvis that stores urine before it is eliminated from the body. These diseases can be caused by a variety of factors, such as infection, inflammation, injury, or congenital abnormalities.
Types of Urinary Bladder Diseases:
1. Urinary Tract Infections (UTIs): These are common bacterial infections that affect the bladder, kidneys, ureters, or urethra.
2. Overactive Bladder (OAB): A condition characterized by sudden, intense urges to urinate, often with urgency and frequency.
3. Benign Prostatic Hyperplasia (BPH): A non-cancerous enlargement of the prostate gland that can cause urinary symptoms such as hesitant or interrupted flow of urine.
4. Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS): A chronic bladder condition characterized by recurring discomfort or pain in the bladder and pelvic area, often accompanied by frequency and urgency.
5. Bladder Cancer: A malignant growth that can occur in the bladder, typically in older adults.
6. Neurological Bladder Dysfunction: Conditions such as spinal cord injury or multiple sclerosis can disrupt the nerve signals that control the bladder, leading to urinary dysfunction.
7. Congenital Bladder Anomalies: Birth defects that affect the development of the bladder, such as bladder exstrophy or cloaca.
Symptoms of Urinary Bladder Diseases:
1. Frequent urination
2. Painful urination
3. Cloudy or strong-smelling urine
4. Blood in the urine
5. Pelvic pain or discomfort
6. Incontinence
7. Urgency to urinate
8. Nocturia (waking up frequently to urinate at night)
9. Bladder pressure or discomfort
10. Difficulty starting or stopping the flow of urine
Diagnosis and Treatment of Urinary Bladder Diseases:
1. Physical examination and medical history
2. Urinalysis and urine culture
3. Imaging tests such as ultrasound, CT scan, or MRI
4. Cystoscopy (insertion of a thin tube with a camera into the bladder)
5. Urodynamic testing (measuring bladder pressure and movement)
6. Biopsy (removing a small sample of tissue for examination)
Treatment options for urinary bladder diseases depend on the underlying cause and severity of symptoms, and may include:
1. Medications such as anticholinergics, antispasmodics, or immunosuppressants
2. Lifestyle changes such as fluid restriction, dietary modifications, or smoking cessation
3. Surgical interventions such as transurethral resection of bladder tumors or bladder augmentation
4. Catheterization or self-catheterization (insertion of a thin tube into the bladder to drain urine)
5. Bladder training and pelvic floor exercises to strengthen the muscles that control urination.
It is important to seek medical attention if you experience any symptoms of urinary bladder diseases, as early diagnosis and treatment can improve outcomes and quality of life.
The presence of blood in urine is typically detected during a urinalysis, which is a routine test performed during a physical examination or when a patient is admitted to the hospital. The amount and color of blood can vary depending on the cause of hematuria, ranging from microscopic (not visible to the naked eye) to gross (visible).
Hematuria can be classified into two main types:
1. Gross hematuria: This type of hematuria is characterized by visible blood in urine, which can range from pink to bright red. It is usually caused by trauma, kidney stones, or tumors.
2. Microscopic hematuria: This type of hematuria is characterized by the presence of red blood cells in urine that are not visible to the naked eye. It can be caused by various factors, including infections, inflammation, and kidney damage.
Hematuria can be a sign of an underlying medical condition, and it is important to consult a healthcare professional if blood is present in urine. A proper diagnosis is essential to determine the cause of hematuria and provide appropriate treatment.
1. Urinary tract infections (UTIs): These are infections that occur in the urinary tract, including the bladder, kidneys, ureters, and urethra. They can be caused by bacteria, viruses, or fungi and can affect people of all ages.
2. Overactive bladder (OAB): This is a condition in which the bladder muscles contract too often, causing urinary frequency, urgency, and sometimes incontinence.
3. Benign prostatic hyperplasia (BPH): This is an enlargement of the prostate gland that can cause urinary symptoms such as difficulty starting or stopping the flow of urine.
4. Kidney stones: These are small, hard mineral deposits that form in the kidneys and can cause severe pain and discomfort.
5. Renal cell carcinoma (RCC): This is a type of cancer that affects the kidneys and can be treated with surgery, ablation, or targeted therapy.
6. Urinary incontinence: This is the loss of bladder control, resulting in involuntary urination. It can be caused by a variety of factors, including weakened pelvic muscles, nerve damage, and overactive bladder.
7. Interstitial cystitis/bladder pain syndrome (IC/BPS): This is a chronic condition characterized by recurring discomfort or pain in the bladder and pelvic area, often accompanied by urinary frequency and urgency.
8. Neurological disorders: Certain neurological conditions such as spinal cord injuries, multiple sclerosis, and spina bifida can affect the nerves that control the bladder and urinary sphincters, leading to urinary incontinence or retention.
9. Prostate issues: Enlarged prostate, benign prostatic hyperplasia (BPH), and prostate cancer can all impact urinary function, leading to symptoms such as difficulty starting or stopping the flow of urine, frequent urination, and weak urine stream.
10. Obstetric trauma: Injuries during childbirth, such as a tear in the pelvic floor muscles or nerve damage, can lead to urinary incontinence or other bladder dysfunction.
It's important to note that some of these conditions may be treatable with medication, surgery, or lifestyle changes, while others may have more long-term implications for urinary function and overall health. If you are experiencing any of these symptoms, it's important to consult with a healthcare provider for proper diagnosis and treatment.
There are several possible causes of urethral obstruction, including:
* Benign prostatic hyperplasia (BPH), a non-cancerous enlargement of the prostate gland that can narrow the urethra.
* Prostatitis, an inflammation of the prostate gland that can cause scarring and narrowing of the urethra.
* Cancer of the prostate or bladder that can obstruct the urethra.
* Trauma to the pelvic area, such as from a fall or a car accident, which can cause damage to the urethra.
* Calculi (stones) in the urinary tract, which can block the flow of urine through the urethra.
* Scar tissue or fibrosis in the urethra due to previous surgery or injury.
* Congenital abnormalities such as a narrowed or blocked urethra present at birth.
Symptoms of urethral obstruction can include:
* Difficulty starting to pass urine
* Painful urination
* Dribbling or spraying of urine
* Inability to pass urine at all (urinary retention)
* Frequent urination
* Pain in the lower abdomen or pelvis
* Blood in the urine
Diagnosis of urethral obstruction is typically made through a combination of physical examination, imaging tests such as X-rays or CT scans, and/or cystoscopy (a procedure in which a thin tube with a camera and light on the end is inserted into the urethra and bladder to visualize the inside of the urinary tract).
Treatment for urethral obstruction depends on the underlying cause and may include:
* Medications to relax the muscles in the urethra or shrink the swelling
* Catheterization, in which a thin tube is inserted into the urethra and bladder to drain urine
* Surgery to remove blockages or repair damaged tissue
* Dilation of the urethra using specialized instruments to widen the opening
* Opening of the blocked urethra by making a small incision in the urethral tissue.
It is important to seek medical attention if you experience any symptoms of urethral obstruction, as untreated blockages can lead to complications such as urinary tract infections, kidney damage, and chronic pain.
Transitional cell carcinoma typically affects older adults, with the average age at diagnosis being around 70 years. Men are more likely to be affected than women, and the risk of developing TCC increases with age and exposure to certain environmental factors such as smoking and exposure to certain chemicals.
The symptoms of TCC can vary depending on the location and stage of the cancer, but may include:
* Blood in the urine (hematuria)
* Painful urination
* Frequent urination
* Pain in the lower abdomen or back
If left untreated, TCC can spread to other parts of the body, including the lymph nodes, liver, and bones. Treatment options for TCC may include surgery, chemotherapy, and immunotherapy, and the prognosis depends on the stage and location of the cancer at the time of diagnosis.
Preventive measures to reduce the risk of developing TCC include maintaining a healthy diet and lifestyle, avoiding smoking and excessive alcohol consumption, and regular screening for bladder cancer. Early detection and treatment can improve the prognosis for patients with TCC.
There are several types of Urinary Bladder Calculi, including:
1. Calcium Oxalate Stones: These are the most common type of bladder stone and are formed from a combination of calcium and oxalate. They can occur in people with conditions such as kidney disease, gout, or inflammatory bowel disease.
2. Uric Acid Stones: These stones are formed from uric acid, a waste product that is normally present in the urine. They can occur in people with conditions such as gout, diabetes, or certain types of cancer.
3. Cystine Stones: These stones are formed from cystine, an amino acid that is present in small amounts in the body. They can occur in people with conditions such as cystinuria, a genetic disorder that affects the transport of cystine and other amino acids in the kidneys.
4. Struvite Stones: These stones are formed from a combination of magnesium, ammonium, and phosphate, and can occur in people with urinary tract infections.
The symptoms of Urinary Bladder Calculi can vary depending on the size and location of the stone, but may include:
1. Severe pain in the lower abdomen or back
2. Frequent urination or a strong, persistent urge to urinate
3. Blood in the urine
4. Cloudy or strong-smelling urine
5. Fever and chills
6. Nausea and vomiting
If you suspect that you have Urinary Bladder Calculi, it is important to seek medical attention as soon as possible. Your healthcare provider may perform a physical examination, take a medical history, and order diagnostic tests such as a urinalysis, imaging studies (such as X-rays or CT scans), or a cystoscopy (a procedure that uses a thin, flexible tube with a camera on the end to examine the inside of the bladder) to confirm the diagnosis and determine the appropriate treatment.
Treatment for Urinary Bladder Calculi may include:
1. Drinking plenty of water to help flush out small stones
2. Medications such as alpha-blockers or potassium citrate to help dissolve larger stones
3. Ureteroscopy, a minimally invasive procedure in which a small, flexible scope is used to remove the stone
4. Lithotripsy, a procedure that uses shock waves to break up larger stones into smaller pieces that can be passed more easily
5. Catheterization, a procedure in which a thin tube is placed through the urethra and bladder to drain urine and flush out small stones
6. Surgery, such as open or laparoscopic surgery, to remove larger stones or repair any damage to the urinary tract.
In some cases, Urinary Bladder Calculi may recur, so it is important to follow up with your healthcare provider regularly to monitor for any new stones or complications.
Treatment options for urinary bladder fistula may include surgery to repair the abnormal connection and restore normal urinary function. In some cases, multiple surgeries may be necessary to achieve complete resolution of symptoms.
Symptoms may include painful urination, frequency of urination, cloudy or strong-smelling urine, and low abdominal discomfort. Interstitial cystitis is often difficult to diagnose and may require a trial of antibiotics or other medications to rule out other conditions such as urinary tract infections or bladder cancer. Treatment options include medications to reduce pain and inflammation, bladder instillation therapy (in which a solution is placed into the bladder through a catheter), and lifestyle modifications such as avoiding trigger foods and drinks and following a high-fiber diet.
In severe cases, surgery may be necessary to remove part of the bladder or create a new opening for urine to pass through (urinary diversion). Interstitial cystitis can have a significant impact on quality of life due to its chronic and unpredictable nature, but with proper treatment and self-care management, many people are able to manage their symptoms and lead active lives.
The most common types of ureteral neoplasms include:
1. Ureteral calculi (stones): Small, hard mineral deposits that form in the ureters and can cause pain and blockage.
2. Ureteral tumors: Both benign and malignant tumors can occur in the ureters, including transitional cell carcinoma, papillary tumors, and ureteral leiomyomas (smooth muscle tumors).
3. Metanephric stromal tumors: Rare tumors that originate in the supporting tissue of the kidney and can occur in the ureters.
4. Wilms' tumor: A rare type of kidney cancer that can spread to the ureters.
Symptoms of ureteral neoplasms may include blood in the urine, pain in the flank or abdomen, frequent urination, and abdominal mass. Diagnosis is typically made with imaging studies such as CT scans and/or ultrasound, followed by a biopsy to confirm the type of tumor. Treatment depends on the type and location of the tumor, and may involve surgery, chemotherapy, or radiation therapy.
1. Urethritis: This is an inflammation of the urethra, often caused by bacterial or viral infections. Symptoms can include burning during urination, frequent urination, and discharge.
2. Urethral stricture: This is a narrowing of the urethra, which can cause difficulty urinating and may require surgical treatment.
3. Urethral cancer: This is a type of cancer that affects the cells lining the urethra. Symptoms can include blood in the urine, painful urination, and weight loss.
4. Benign prostatic hyperplasia (BPH): This is a non-cancerous enlargement of the prostate gland, which can cause symptoms such as frequent urination, difficulty starting or stopping urination, and incontinence.
5. Prostatitis: This is inflammation of the prostate gland, which can cause symptoms such as painful urination, frequency, and discomfort during sex.
6. Erectile dysfunction (ED): This is the inability to achieve or maintain an erection sufficient for satisfactory sexual performance. It can be caused by a range of factors, including urethral diseases.
7. Premature ejaculation: This is when a man experiences orgasm and expels semen too quickly, often before he or his partner is ready. It can be caused by a range of factors, including urethral diseases.
8. Urinary tract infections (UTIs): These are infections that affect the urinary tract, including the urethra, bladder, and kidneys. Symptoms can include burning during urination, frequent urination, and discomfort during sex.
9. Interstitial cystitis: This is a chronic condition characterized by recurring discomfort or pain in the bladder and pelvic area, often accompanied by frequency and urgency of urination.
10. Peyronie's disease: This is a condition that causes the development of scar tissue inside the penis, which can lead to curvature, shrinkage, and pain during sex.
It is important to note that many of these conditions can have similar symptoms, making it difficult to diagnose them without proper medical testing and evaluation. If you are experiencing any of these symptoms, it is important to consult with a healthcare professional for an accurate diagnosis and appropriate treatment.
Cystoscopy
Glomerulation
Prostate cancer
Maximilian Nitze
Mark Soloway
Posterior urethral valve
Cystography
Urogynecology
Bladder cancer
Interstitial cystitis
Arthur D. Hirschfelder
Ureteric stent
Howard Atwood Kelly
Neurogenic bladder dysfunction
Narrow-band imaging
Douglas Scherr
1910 in science
Laparoscopy
Urethral cancer
Gynaecology
Urinary bladder
Scarabiasis
Urinary retention
Urethrotomy
Vaginal evisceration
Aminolevulinic acid
Valsalva maneuver
Paraphimosis
Vesicouterine fistula
Georges Marion
Cystoscopy & Ureteroscopy - NIDDK
Cystoscopy: MedlinePlus Medical Encyclopedia
Cystoscopy: MedlinePlus Medical Encyclopedia
Cystoscopy at North Staffordshire Hospital
Cystoscopy and Urethroscopy in the Assessment of Urinary Incontinence: Overview, Cystourethroscopy, Dynamic Retrograde...
Video from Cystoscopy Turned to High Resolution 3D Organ Model
Rigid Cystoscopy | AdventHealth Medical Group | AdventHealth
Photocure Seeks Expanded Use of Blue Light Cystoscopy - Renal and Urology News
52277 Cystoscopy and treatment - ClearHealthCosts
Detection of the recurrence of superficial urothelial carcinoma of urinary bladder by combined urine cytology and cystoscopy
...
Cystoscopy And Erectile Dysfunction - wsscheduler.com
Cystoscopy | EMS Urology
Urethro-cystoscopy Sheath Endoscope
NHANES 2007-2008: Prostate Specific Antigen (PSA) Data Documentation, Codebook, and Frequencies
Diagnosing Urological Problems with a Cystoscopy - Urologic Institute
Sling News, Research - Page 2
Diagnostic and therapeutic cystoscopy in bladder pain syndrome/interstitial cystitis: systematic review of literature and...
What Does Bladder Cancer Look Like On A Cystoscopy - HealthyBladderClub.com
Small Animals | KARL STORZ Endoskope | Argentina
184 OB/GYN Grand Rounds: "Universal Cystoscopy for Benign Hysterectomy: Friend or Foe?" (072016) | UT Southwestern
Urology & Urologic Disease Treatment at Carondelet
Prostate Cancer - McKenzie-Willamette Medical Center
Eunice Kennedy Shriver National Institute of Child Health and Human Development - NICHD
A 12 year old with recurrent urinary tract infections and hematuria undergoes cystoscopy-UKMLA PLAB AMC USMLE Prometric MCQ
How We Diagnose Bladder Cancer - Dana-Farber Cancer Institute | Boston, MA
Video - Results from #90
2021 MIPS Measure #422: Performing Cystoscopy at the Time of Hysterectomy for Pelvic Organ Prolapse to Detect Lower Urinary...
Welcome to Lehigh Valley Health Network | Lehigh Valley Health Network
Biopsy4
- The study was aimed to evaluate the accuracy of combined urine cytology and cystoscopy for the detection of the recurrence of superficial urothelial carcinoma of urinary bladder without bladder biopsy. (banglajol.info)
- Urine cytology as well as cystoscopy were done with a targeted biopsy taken from any apparently visible growth in the bladder. (banglajol.info)
- If bladder cancer is found after a biopsy or cystoscopy, tests may be conducted to determine if the cancer cells have spread beyond the bladder to other parts of the body. (dana-farber.org)
- Diagnosis may be confirmed by cystoscopy and biopsy. (cdc.gov)
Rigid Cystoscopy3
- A rigid cystoscopy is so-named because of the telescopic instrument (called a cystoscope) that is used to perform it. (adventhealth.com)
- During rigid cystoscopy , the procedure is similar to flexible cystoscopy but as the patient is usually under general anesthesia they will not be aware of any associated physical sensations. (healthybladderclub.com)
- In patients who undergo rigid cystoscopy, side effects associated with anesthesia may be experienced. (healthybladderclub.com)
Perform cystoscopy2
- Why do health care professionals perform cystoscopy? (nih.gov)
- Cysview is used with the Karl Storz D-Light C Photodynamic Diagnostic System to perform cystoscopy with the blue light setting (mode 2) as an adjunct to the white light setting (mode 1). (renalandurologynews.com)
Intraoperative cystoscopy1
- Free-flowing indigo carmine is observed from the ureteral orifice during intraoperative cystoscopy. (medscape.com)
Urine1
- Less commonly, patients may be temporarily unable to pass urine after a cystoscopy and it may be necessary for a catheter to be inserted into the bladder to enable emptying. (healthybladderclub.com)
Cystoscope4
- Cystoscopy is a procedure that uses a cystoscope to look inside the urethra and bladder . (nih.gov)
- Cystoscopy is done with a cystoscope. (nih.gov)
- A cystoscopy is a procedure that allows the urologist to explore the bladder and the urethra using an endoscope specifically designed for this and called a cystoscope. (ems-urology.com)
- During a cystoscopy, an instrument called a cystoscope is inserted into the urethra in order to allow Dr. Ilbeigi to look inside the urethra and bladder. (urologic.institute)
Urology1
- A cystoscopy is a procedure used by urology experts like Dr. Pedram Ilbeigi in order to diagnose issues with a patient's bladder or urethra. (urologic.institute)
Ureteroscopy5
- What are cystoscopy and ureteroscopy? (nih.gov)
- Cystoscopy and ureteroscopy are common procedures performed by a urologist to look inside the urinary tract . (nih.gov)
- How do I prepare for a cystoscopy or ureteroscopy? (nih.gov)
- Your urologist will ask about your medical history to determine whether you need a cystoscopy or ureteroscopy. (nih.gov)
- To prepare for a cystoscopy or ureteroscopy, your urologist will talk with you about anesthesia, give you instructions for what to do before the procedure, and discuss what to expect afterward. (nih.gov)
Urinary tract infe1
- For instance, a patient who is has frequent urinary tract infections may need a cystoscopy to understand the cause of the infections. (urologic.institute)
Cytology1
- Reports of the cytology and cystoscopy were compared with the histopathology reports. (banglajol.info)
Hysterectomy1
- 184 OB/GYN Grand Rounds: "Universal Cystoscopy for Benign Hysterectomy: Friend or Foe? (utsouthwestern.edu)
Tumor1
- This is often done with cystoscopy, proctoscopy, and tumor biopsies at the same time. (sgo.org)
Ureteral1
- Other rare causes are secondary to In studies involving routine cystoscopy, the cervicocystopexies both pubic or vaginal, ovarian frequency of ureteral injury varied from 0 to 26.8 surgeries and uterine aspiration. (who.int)
Hematuria1
- In general, cystoscopy is indicated for patients with persistent irritative voiding symptoms, hematuria, postoperative incontinence, voiding dysfunction, and suspicion of a urethral diverticulum or fistula. (medscape.com)
Urologist1
- During a cystoscopy, a urologist can sometimes treat problems, such as bleeding in the bladder and blockage in the urethra. (nih.gov)
Anesthesia1
- Other patients prefer general anesthesia so that they are not awake during the cystoscopy process. (urologic.institute)
Complications1
- Cystoscopy is usually a safe procedure and serious complications are uncommon. (healthybladderclub.com)
Patients8
- In July 2010, FDA approved Cysview for use in the cystoscopic detection of non-muscle-invasive papillary bladder cancer in patients suspected or known to have lesions on the basis of prior cystoscopy. (renalandurologynews.com)
- Hexaminolevulinate HCl is an optical imaging agent indicated for use in the cystoscopic detection of non-muscle-invasive papillary bladder cancer in patients suspected or known to have lesions on the basis of prior cystoscopy. (renalandurologynews.com)
- Cystoscopy has been routinely performed in patients suspected to be suffering from bladder pain syndrome / interstitial cystitis (BPS/IC) across the globe. (bvsalud.org)
- The aim was to review the literature describing the prevalent techniques of cystoscopy for patients of BPS/IC and try to evolve a consensus . (bvsalud.org)
- It is important to have a uniform standardized technique for performing a diagnostic and therapeutic cystoscopy in patients with BPS/IC. (bvsalud.org)
- Joshua Meeks joins Alicia Morgans to review his approach to cystoscopy using blue light and Cysview®, and how to best choose patients that will maximally benefit from that kind of technology. (urotoday.com)
- Patients suspected to have genital urinary with the use of cystoscopy and were managed injuries underwent, pre-treatment evaluations successfully intra-operatively. (who.int)
- In patients having daytime symptoms of frequency and urgency, examination should include voiding cystourethrography and cystoscopy, as necessary. (nih.gov)
Lesions2
- On the other hand, cystoscopy helps detect bladder lesions and identify other pathologies. (medscape.com)
- The group the Global Interstitial Cystitis , Bladder Pain Society (GIBS) has worked collectively to systematically review the literature using the key words, " Cystoscopy in Hunner's lesions, bladder pain syndrome , painful bladder syndrome and interstitial cystitis " in the PubMed , COCHRANE, and SCOPUS databases. (bvsalud.org)
Routine1
- As described in journal Biomedical Optics Express , the technique does not require special hardware beyond that already used during routine cystoscopies. (medgadget.com)
Urethra1
- During flexible cystoscopy , the patient lies on their back and an anesthetic gel is passed into the urethra to make the area numb. (healthybladderclub.com)
Treatment1
- Trinity Bivalacqua joins Ashish Kamat to discuss the role of blue light cystoscopy in bladder cancer treatment, specifically regarding non-muscle invasive disease. (urotoday.com)
Blue light1
- Dr. Bivalacqua also explains how blue light cystoscopy can. (urotoday.com)
Small1
- Cystoscopy is best used in combination with other tests to confirm early-stage or small tumors. (dana-farber.org)
Special1
- In some cases, you won't need special preparations for a cystoscopy. (nih.gov)
Helps1
- A Cystoscopy helps. (mckweb.com)
Patient1
- MATERIALS AND METHODS: Cystoscopy surveillance of the first American cancer patient treated with dicycloplatin was performed quarterly. (nih.gov)
Techniques1
- 5. Cystoscopy: techniques and clinical applications. (nih.gov)
Performed often1
- The cystoscopy is a safe and effective procedure that is performed often in urological offices. (urologic.institute)
Cases1
- The group went on to arrive at a consensus for a stepwise technique of diagnostic and therapeutic cystoscopy in cases of BPS/IC. (bvsalud.org)
Health3
- Get rapid access to a cystoscopy at our Nuffield Health Hospital's. (nuffieldhealth.com)
- Why choose Nuffield Health for your cystoscopy? (nuffieldhealth.com)
- At Nuffield Health Hospitals, our expert urologists specialise in cystoscopies. (nuffieldhealth.com)
Review2
- Diagnostic and therapeutic cystoscopy in bladder pain syndrome/interstitial cystitis: systematic review of literature and consensus on methodology. (bvsalud.org)
- A total of 3,857 abstracts were studied and 96 articles referring to some part of technique of cystoscopy were short-listed for review as full-length articles. (bvsalud.org)
Common1
- cystoscopy and erectile dysfunction This can be a awkward and frustrating issue for numerous men, but it is also a common one. (wsscheduler.com)
Description1
- Finally, six articles with a description of a technique of cystoscopy were included for final tabulation and comparison. (bvsalud.org)